Table: Fractale -2018/19 group results

ADR Biomedical Holdings

14/05/2019 07:00

May 14 (Reuters)- 
          Fractale Corporation 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           1.92           522 mln         2.80                  
              (+268.6 pct)     (-80.6 pct)    (+45.5 pct)              
  Operating      293 mln         130 mln        440 mln                
              (+124.8 pct)                    (+50.0 pct)              
  Recurring      204 mln         127 mln        390 mln                
               (+60.3 pct)                    (+90.8 pct)              
  Net                                           380 mln                
                                              (-35.9 pct)              
  Net            592 mln         449 mln                               
               (+31.7 pct)                                             
  EPS           88.30 yen       66.25 yen      56.61 yen               
  Ann Div       20.00 yen       10.00 yen      20.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       20.00 yen       10.00 yen      20.00 yen               
  
  NOTE - Fractale Corporation.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3750.T